Licensing Flu Shot Study
NCT01440205 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6098
Last updated 2016-09-14
Summary
The mailer will encourage all employees of one of Evive's partner companies to attend an on-site free flu shot clinic they are offering in the fall of 2011. The research will examine differences in follow-through on getting a flu shot at an on-site clinic among the targeted population during the \~1 month period when clinics are being offered (following the mailing) as a function of experimental condition.
Conditions
Interventions
- BEHAVIORAL
-
Easy list of healthy habits
The recipient will be prompted to check off "yes" or "no" to healthy habits that most people will find fairly easy.
- BEHAVIORAL
-
Challenging list of healthy habits
The recipient will be prompted to check off "yes" or "no" to healthy habits that most people will find fairly difficult.
- BEHAVIORAL
-
Control
No check box element
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Katherine L Milkman, Ph.D. · University of Pennsylvania
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2011-10-31
- Completion
- 2012-05-31
Countries
- United States
Study Locations
More Related Trials
-
Flu Shot Pre-visit Questionnaire
NCT05508698 ·Status: COMPLETED ·Phase: NA
-
Nudge and Motivational Interviewing Interventions to Improve Influenza Vaccine Uptake Among Healthcare Workers in China
NCT07157163 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Personalized Nudging to Increase Influenza Vaccinations
NCT06566534 ·Status: COMPLETED ·Phase: NA
-
Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines
NCT01674205 ·Status: COMPLETED ·Phase: PHASE1
-
Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years
NCT03101462 ·Status: COMPLETED ·Phase: PHASE4
-
Self-Administered Nasal Influenza Feasibility Study
NCT01933048 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating Immune Response to Seasonal FluMist in Healthy Adults
NCT01673425 ·Status: TERMINATED ·Phase: NA
-
The Effect of a Planning Prompt on Seasonal Influenza Vaccination Rates
NCT01207232 ·Status: COMPLETED ·Phase: NA
-
From Innovation to Solutions: Childhood Influenza Vaccination Planning
NCT01664793 ·Status: COMPLETED ·Phase: NA
-
Promotion of Influenza Vaccination in Healthcare Workers During the Recruitment Visit
NCT02758145 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination
NCT07133802 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program
NCT00192218 ·Status: COMPLETED ·Phase: PHASE4
-
Influenza Vaccine Challenge Study in Healthy Subjects
NCT01226758 ·Status: COMPLETED ·Phase: PHASE1
-
Collaborative Efforts to Increase Flu Vaccination
NCT01403649 ·Status: COMPLETED ·Phase: NA
-
Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024)
NCT03023683 ·Status: COMPLETED ·Phase: PHASE4
-
FLU-VACS Comparative Study in Adults
NCT00133523 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Text Message for Influenza Vaccination
NCT01761734 ·Status: COMPLETED ·Phase: NA
-
SAVE: School Ambassadors for Vaccine Education
NCT07164144 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants
NCT00192335 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™).
NCT02143882 ·Status: COMPLETED ·Phase: PHASE4
-
Infectivity, Replication & Immunogenicity of Live nH1N1 Vaccine
NCT01023776 ·Status: COMPLETED ·Phase: PHASE4
-
Health Management Training to Enhance Influenza Vaccine Immunogenicity
NCT01256515 ·Status: COMPLETED ·Phase: NA
-
Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4
NCT00538512 ·Status: COMPLETED ·Phase: PHASE4
-
Immunologic Response to Influenza Vaccination in Children and Adolescents
NCT03614975 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v Disease
NCT02883426 ·Status: TERMINATED ·Phase: PHASE1